University of Texas's Southwestern Medical Center: Study Proves Hepatitis C Drugs Reduce Liver-Related Deaths by Nearly Half
August 09, 2019
August 09, 2019
DALLAS, Texas, Aug. 9 -- The University of Texas's Southwestern Medical Center issued the following news:
A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer.
The finding builds on a December 2018 study by the same researchers who found that antiviral drugs do not increase the risk of liver cancer recurrence, as was . . .
A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer.
The finding builds on a December 2018 study by the same researchers who found that antiviral drugs do not increase the risk of liver cancer recurrence, as was . . .